125 related articles for article (PubMed ID: 2429079)
41. Effect of hypo- and hyperthyroidism on binding of [3H]-nitrendipine to myocardial and brain membranes.
Kosinski C; Gross G; Hanft G
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):128S-130S. PubMed ID: 2176516
[TBL] [Abstract][Full Text] [Related]
42. Competitive binding experiments reveal differential interactions for dihydropyridine calcium channel activators and antagonists at dihydropyridine receptors on mouse brain membranes.
O'Neill SK; Triggle CR; Bolger GT
Can J Physiol Pharmacol; 1994 Jul; 72(7):738-45. PubMed ID: 7530159
[TBL] [Abstract][Full Text] [Related]
43. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
Homaidan FR; Donowitz M; Weiland GA; Sharp GW
Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
[TBL] [Abstract][Full Text] [Related]
45. Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.
Motulsky HJ; Snavely MD; Hughes RJ; Insel PA
Circ Res; 1983 Feb; 52(2):226-31. PubMed ID: 6297831
[TBL] [Abstract][Full Text] [Related]
46. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
Bolger GT; Skolnick P
Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
[TBL] [Abstract][Full Text] [Related]
47. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
Miwa K; Miyagi Y; Araie E; Sasayama S
Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
[TBL] [Abstract][Full Text] [Related]
48. Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.
Chatelain P; Dewinkeleer P; Beaufort P; Meysmans L; Clinet M
Eur J Pharmacol; 1994 Apr; 267(2):151-60. PubMed ID: 8050476
[TBL] [Abstract][Full Text] [Related]
49. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
[TBL] [Abstract][Full Text] [Related]
50. Modulation of cardiac calcium channels by propofol.
Zhou W; Fontenot HJ; Liu S; Kennedy RH
Anesthesiology; 1997 Mar; 86(3):670-5. PubMed ID: 9066334
[TBL] [Abstract][Full Text] [Related]
51. Increased [3H]nitrendipine binding sites in rat heart during adult maturation and aging.
Navaratnam S; Khatter JC
Biochem Pharmacol; 1991 Feb; 41(4):593-600. PubMed ID: 1847636
[TBL] [Abstract][Full Text] [Related]
52. [3H]-nitrendipine binding in membranes obtained from hypoxic and reoxygenated heart.
Matucci R; Bennardini F; Sciammarella ML; Baccaro C; Stendardi I; Franconi F; Giotti A
Biochem Pharmacol; 1987 Apr; 36(7):1059-62. PubMed ID: 3032202
[TBL] [Abstract][Full Text] [Related]
53. Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane.
Rogart RB; deBruyn Kops A; Dzau VJ
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7452-6. PubMed ID: 2429306
[TBL] [Abstract][Full Text] [Related]
54. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
55. Lactamimides: a novel chemical class of calcium antagonists with diltiazem-like properties.
Palfreyman MG; Dudley MW; Cheng HC; Mir AK; Yamada S; Roeske WR; Obata T; Yamamura HI
Biochem Pharmacol; 1989 Aug; 38(15):2459-65. PubMed ID: 2757648
[TBL] [Abstract][Full Text] [Related]
56. Calcium antagonism and structure-affinity relationships of terfenadine, a histamine H1 antagonist, and some related compounds.
Zhang MQ; Caldirola P; Timmerman H
J Pharm Pharmacol; 1993 Jan; 45(1):63-6. PubMed ID: 8094450
[TBL] [Abstract][Full Text] [Related]
57. [3H]nitrendipine binding to adrenal capsular membranes.
Finkel MS; Aguilera G; Catt KJ; Keiser HR
Life Sci; 1984 Aug; 35(8):905-10. PubMed ID: 6482681
[TBL] [Abstract][Full Text] [Related]
58. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
[TBL] [Abstract][Full Text] [Related]
59. Interaction between propranolol and calcium channel blockers in cardiac and vascular smooth muscle.
Weishaar RE; Quade MM; Pugsley TA; Shih YH; Taylor DG
J Mol Cell Cardiol; 1988 Oct; 20(10):897-903. PubMed ID: 3216400
[TBL] [Abstract][Full Text] [Related]
60. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
Bellemann P; Ferry D; Lübbecke F; Glossmann H
Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
